Pharmaceutical Supply – Azithromycin Tablets

The contract encompasses the supply of FDA-regulated Azithromycin Tablets identified by NSN 6505-01-449-1618, with stringent requirements for adherence to shelf-life standards, full lot traceability, and compliance with original manufacturer specifications. All deliveries must ensure product integrity and regulatory alignment, as this pharmaceutical is intended for use within Department of Defense medical supply channels, specifically supporting operations tied to Fort Bragg, North Carolina. The subcontract is governed under NAICS code 325412, indicating classification within pharmaceutical preparation manufacturing, and is subject to the procurement protocols of the Medical Supply Chain Pharm FSA under the Department of Defense. Responses to this solicitation must be submitted by July 20, 2026, with the posting date set for July 14, 2026, indicating a limited six-day window for qualified suppliers to submit proposals. The contract does not specify a set-aside classification and lacks a designated point of contact, suggesting that all inquiries and submissions must follow standard DLA procedures via the official DIBBS portal. Full compliance with federal pharmaceutical handling and distribution regulations is mandatory, and successful bidders will be expected to maintain end-to-end documentation for each lot, ensuring accountability from manufacturing through final delivery to the designated military installation.